This page is a guide to IBB, the iShares Nasdaq Biotechnology ETF offered by iShares.
Last Price
$256.24
+N/A
How is IBB Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does IBB Compare to Its Category Competitors?
The percentile shown for each metric indicates how IBB compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$6,267.62
96th Percentile
Dividend Yield
0.03%
7th Percentile
Returns
YTD Return
-21.02%
3rd Percentile
5 Year Return
23.50%
99th Percentile
Portfolio
Number of Holdings
191
91st Percentile
% Assets in Top 10
62.10%
21st Percentile
Expenses
Expense Ratio
0.48%
47th Percentile
Fund Turnover
33.00%
28th Percentile
IBB vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for IBB as well as all other ETFs in the Sector Stock category. To compare IBB to its broader asset class peer group, visit the Stock page. To compare IBB to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for IBB and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 32.69% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.78% |
IBB Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 96.68% |
| Non US Stock Weighting | 3.25% |
| Other Weighting | 0.07% |
| Top Holdings | Weight |
|---|---|
| Biogen Inc | 9.53% |
| Amgen Inc | 9.49% |
| Celgene Corp | 9.17% |
| Gilead Sciences Inc | 7.84% |
| Regeneron Pharmaceuticals Inc | 7.38% |
| Mylan NV | 4.62% |
| Illumina Inc | 4.13% |
| Alexion Pharmaceuticals Inc | 4.09% |
| Vertex Pharmaceuticals Inc | 3.51% |
| Incyte Corp | 2.34% |
Other IBB Metrics
Management
- Issuer
- iShares
- Inception Date
- 02/05/2001
- Management Style
- Passive
- Benchmark
- NASDAQ Biotechnology TR USD
Dividend Data
- Dividend Frequency
- Quarterly
- Capital Gains Frequency
- Annually
- Annual Dividend
- $0.13
Pricing Data
- Day Range
- $252.85 / $264.77
- Bid/Ask
- $256.13 / $256.24
- 52 Week Low/High
- $251.63 / $400.79
Other Information
- Leveraged Fund
- No
